bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
3.540
-0.460 (-11.50%)
At close: Mar 30, 2026, 4:00 PM EDT
3.520
-0.020 (-0.56%)
Pre-market: Mar 31, 2026, 6:38 AM EDT

bioAffinity Technologies Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6.169.362.530-
Revenue Growth (YoY)
-34.18%269.68%52627.44%--
Cost of Revenue
4.235.981.740-
Gross Profit
1.943.380.790-
Selling, General & Admin
9.919.946.792.481.07
Depreciation & Amortization Expenses
0.50.610.250.01-
Research & Development
2.091.781.721.521.14
Total Operating Expenses
12.5112.338.764.022.21
Operating Income
-10.57-8.95-7.97-4.01-2.21
Interest Income
0.020.020.120.050
Interest Expense
-0.04-0.09-0.04-2.53-1
Other Non-Operating Income (Expense)
-4.270-0.03-1.65-3.12
Total Non-Operating Income (Expense)
-4.29-0.070.06-4.14-4.12
Pretax Income
-14.87-9.03-7.92-8.15-6.32
Provision for Income Taxes
-0.04-0.01-0.02-0-0
Net Income
-14.91-9.04-7.94-8.15-6.33
Net Income to Common
-14.91-9.04-7.94-8.15-6.33
Shares Outstanding (Basic)
20000
Shares Outstanding (Diluted)
20000
Shares Change (YoY)
325.83%38.61%94.43%67.83%0.31%
EPS (Basic)
-8.66-22.50-27.30-54.30-70.80
EPS (Diluted)
-8.66-22.50-27.30-54.30-70.80
Shares Outstanding
4.50.520.310.280.09
Free Cash Flow
-9.39-7.34-6.06-4.29-2.05
Free Cash Flow Per Share
-5.46-18.17-20.79-28.61-
Gross Margin
31.40%36.09%31.26%90.28%-
Operating Margin
-171.58%-95.64%-314.84%-83511.51%-
Profit Margin
-241.96%-96.56%-313.41%-169771.25%-
FCF Margin
-152.38%-78.44%-239.32%-89336.50%-
EBITDA
-10.07-8.35-7.72-4-2.2
EBITDA Margin
-163.38%-89.17%-304.98%-83299.52%-
EBIT
-10.57-8.95-7.97-4.01-2.21
EBIT Margin
-171.58%-95.64%-314.84%-83511.51%-
Effective Tax Rate
0.30%0.13%0.27%0.03%0.03%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q